99 related articles for article (PubMed ID: 17092549)
1. The pattern of CD98 expression is different between uterine serous papillary carcinoma and endometrioid endometrial carcinoma.
Monaghan H; Williams AR
Gynecol Oncol; 2007 Jan; 104(1):264-5. PubMed ID: 17092549
[No Abstract] [Full Text] [Related]
2. Human kallikrein 6: a new potential serum biomarker for uterine serous papillary cancer.
Santin AD; Diamandis EP; Bellone S; Soosaipillai A; Cane S; Palmieri M; Burnett A; Roman JJ; Pecorelli S
Clin Cancer Res; 2005 May; 11(9):3320-5. PubMed ID: 15867230
[TBL] [Abstract][Full Text] [Related]
3. Zone Formation of Lymphocyte Infiltration at the Invasive Front Results in the Prolonged Survival of Individuals With Endometrial Serous Carcinoma and Endometrioid Carcinoma With Serous Component.
Miyamoto M; Takano M; Tsuda H; Ishibashi H; Soyama H; Matsuura H; Sakamoto T; Aoyama T; Iwahashi H; Furuya K
Anticancer Res; 2019 Apr; 39(4):2085-2089. PubMed ID: 30952753
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of kallikrein 10 (hK10) in uterine serous papillary carcinomas.
Santin AD; Diamandis EP; Bellone S; Marizzoni M; Bandiera E; Palmieri M; Papasakelariou C; Katsaros D; Burnett A; Pecorelli S
Am J Obstet Gynecol; 2006 May; 194(5):1296-302. PubMed ID: 16647913
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of clusterin according to histological type of endometrial carcinoma.
Ahn HJ; Bae J; Lee S; Ko JE; Yoon S; Kim SJ; Sakuragi N
Gynecol Oncol; 2008 Aug; 110(2):222-9. PubMed ID: 18514801
[TBL] [Abstract][Full Text] [Related]
6. Local immune response in serous papillary carcinoma of the endometrium.
Tamiolakis D; Venizelos J; Lambropoulou M; Nikolaidou S; Tsikouras P; Jivannakis T; Papadopoulos N
Histol Histopathol; 2005 Apr; 20(2):403-8. PubMed ID: 15736043
[TBL] [Abstract][Full Text] [Related]
7. cDNA microarray analysis and immunohistochemistry reveal a distinct molecular phenotype in serous endometrial cancer compared to endometrioid endometrial cancer.
Chen Y; Yao Y; Zhang L; Li X; Wang Y; Zhao L; Wang J; Wang G; Shen D; Wei L; Zhao J
Exp Mol Pathol; 2011 Aug; 91(1):373-84. PubMed ID: 21540026
[TBL] [Abstract][Full Text] [Related]
8. [Uterine papillary serous carcinoma--a different kind of tumor].
Steinman N; Avni A
Harefuah; 1999 May; 136(10):810-2. PubMed ID: 10955120
[No Abstract] [Full Text] [Related]
9. Differential expression of WT-1 in serous carcinomas in the peritoneum with or without associated serous carcinoma in endometrial polyps.
Euscher ED; Malpica A; Deavers MT; Silva EG
Am J Surg Pathol; 2005 Aug; 29(8):1074-8. PubMed ID: 16006803
[TBL] [Abstract][Full Text] [Related]
10. Endometrial carcinoma in one horn of a bicornuate uterus.
Moore JR; Davidson SA; Singh M
Gynecol Oncol; 2004 Dec; 95(3):729-32. PubMed ID: 15581992
[TBL] [Abstract][Full Text] [Related]
11. WT-1 in ovarian and endometrioid serous carcinoma: a meta-analysis.
Heatley MK
Histopathology; 2005 Apr; 46(4):468. PubMed ID: 15810962
[No Abstract] [Full Text] [Related]
12. Wilms' tumor gene 1 (WT1) in endometrial carcinoma.
Coosemans A; Moerman P; Verbist G; Maes W; Neven P; Vergote I; Van Gool SW; Amant F
Gynecol Oncol; 2008 Dec; 111(3):502-8. PubMed ID: 18929401
[TBL] [Abstract][Full Text] [Related]
13. MMP-2, TIMP-1, E-cadherin, and beta-catenin expression in endometrial serous carcinoma compared with low-grade endometrial endometrioid carcinoma and proliferative endometrium.
Shaco-Levy R; Sharabi S; Piura B; Sion-Vardy N
Acta Obstet Gynecol Scand; 2008; 87(8):868-74. PubMed ID: 18607832
[TBL] [Abstract][Full Text] [Related]
14. Strategies for distinguishing low-grade endometrioid and serous carcinomas of endometrium.
Garg K; Soslow RA
Adv Anat Pathol; 2012 Jan; 19(1):1-10. PubMed ID: 22156830
[TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinase-2 (MMP-2): a major player in the progression of systemic malignancies besides endometrial serous carcinomas.
Kapoor S
Acta Obstet Gynecol Scand; 2008; 87(11):1259. PubMed ID: 18763172
[No Abstract] [Full Text] [Related]
16. Thyroid transcription factor-1 expression in endometrial and endocervical adenocarcinomas.
Siami K; McCluggage WG; Ordonez NG; Euscher ED; Malpica A; Sneige N; Silva EG; Deavers MT
Am J Surg Pathol; 2007 Nov; 31(11):1759-63. PubMed ID: 18059234
[TBL] [Abstract][Full Text] [Related]
17. The role of matrix metalloproteinases-2, -7 and -9 and beta-catenin in high grade endometrial carcinoma.
Monaghan H; MacWhinnie N; Williams AR
Histopathology; 2007 Feb; 50(3):348-57. PubMed ID: 17257130
[TBL] [Abstract][Full Text] [Related]
18. [Pathology of endometrial carcinoma].
Shiozawa T; Konishi I
Nihon Rinsho; 2004 Oct; 62 Suppl 10():273-8. PubMed ID: 15535250
[No Abstract] [Full Text] [Related]
19. [Endometrial carcinoma and precursor lesions].
Djordjević B; Stanojević Z
Srp Arh Celok Lek; 2007; 135(3-4):230-4. PubMed ID: 17642468
[TBL] [Abstract][Full Text] [Related]
20. Serous EIC as an early form of uterine papillary serous carcinoma: recent progress in understanding its pathogenesis and current opinions regarding pathologic and clinical management.
Zheng W; Schwartz PE
Gynecol Oncol; 2005 Mar; 96(3):579-82. PubMed ID: 15721397
[No Abstract] [Full Text] [Related]
[Next] [New Search]